|
|
Binance |
|
|
Coinbase |
|
|
KUCOIN |
|
|
AscendEX (Formally BitMax) |
By Trader Edge at 2026-09-30 04:55
Sentiment: Negative
TLDR BTIG raised its price target on Tempus AI from $70 to $80, maintaining a Buy rating, sending the stock up 6.9% to $66.21 The move is also linked to a major cancer trial milestone involving Merck and Moderna’s mRNA therapy, which uses Personalis’ sequencing platform Tempus AI agreed last month to acquire Personalis for [...] The post Tempus AI (TEM) Stock Jumps 7% on Analyst Upgrade and Cancer Trial News appeared first on CoinCentral. Continue reading...
Categories: Stocks
Tags: #Stocks
Source Coin Central